siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells

He,Zhiyong; Huang,Chuanzhong; Lin,Gen; Ye,Yunbin

doi:10.3892/or.2016.4602

siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells

Authors:
- Zhiyong He
- Chuanzhong Huang
- Gen Lin
- Yunbin Ye
View Affiliations

Affiliations: Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Teaching Hospital, Fuzhou, Fujian 350014, P.R. China
Published online on: February 1, 2016 https://doi.org/10.3892/or.2016.4602
Pages: 1933-1940
Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tumor necrosis factor receptor-associated factor 6 (TRAF6) has been found to be involved in multiple cancers. However, the effect of small interfering RNA (siRNA)‑induced knockdown of TRAF6 on the biological behaviors of cancer cells remains unknown. Thus, the present study aimed to investigate the effect of siRNA-induced knockdown of TRAF6 on the biological behaviors of human lung cancer SPC-A1 cells. The expression of TRAF6 was determined in human lung adenocarcinoma A549, non-small cell lung cancer H1650, human airway epithelial Calu-3 and human lung cancer SPC-A1 cell lines using quantitative RT-PCR (qRT‑PCR) and western blotting at the transcriptional and translational levels. TRAF6 expression was knocked down in the SPC-A1 cells using an siRNA technique, and the effects of TRAF6 knockdown on NF-κB activity, cell proliferation, apoptosis, cell cycle, invasion and migration of the SPC-A1 cells were determined using electrophoretic mobility shift assay (EMSA), cell proliferation assay, flow cytometry, Transwell invasion assay and scratch wound assay. In addition, the protein expression of CD24, CXCR4, MMP1, MMP2, MMP9, TWIST, TIMP-2 and Slug was quantified using western blotting assay. Western blotting and qRT-PCR assays showed upregulation of TRAF6 at both the translational and transcriptional levels in the Calu-3 and SPC-A1 cells, and K63-linked ubiquitination of TRAF6 and constitutive NF-κB activation were detected in the SPC-A1 cells. Knockdown of TRAF6 inhibited the migration and invasion and promoted the apoptosis of the SPC-A1 cells, but had little effect on cell proliferation and the cell cycle. In addition, siRNA-induced TRAF6 knockdown caused a marked reduction in the protein expression of CD24 and CXCR4, but had little effect on MMP-1, MMP-2, MMP-9, Twist, TIMP-2 or Slug expression. The present study demonstrated that TRAF6 is upregulated in human lung cancer cells, and siRNA-induced TRAF6 knockdown inhibits the invasion of lung cancer cells and promotes apoptosis. It is suggested that TRAF6 may be a promising target for the therapy of lung cancer.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
2	Herbst RS, Heymach JV and Lippman SM: Lung cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
3	GBD 2013 Mortality and Causes of Death Collaborators: Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 385:117–171. 2015. View Article : Google Scholar
4	Miller YE: Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol. 33:216–223. 2005. View Article : Google Scholar : PubMed/NCBI
5	Syrigos KN, Katirtzoglou N, Kotteas E and Harrington K: Adhesion molecules in lung cancer: Implications in the pathogenesis and management. Curr Pharm Des. 14:2173–2183. 2008. View Article : Google Scholar : PubMed/NCBI
6	Gazdar AF and Minna JD: Angiogenesis and the multistage development of lung cancers. Clin Cancer Res. 6:1611–1612. 2000.PubMed/NCBI
7	Balkwill F: Cancer and the chemokine network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar : PubMed/NCBI
8	Hodkinson PS, Mackinnon A and Sethi T: Targeting growth factors in lung cancer. Chest. 133:1209–1216. 2008. View Article : Google Scholar : PubMed/NCBI
9	Sethi T and Woll PJ: Growth factors and lung cancer. Cancer Treat Res. 72:111–130. 1995. View Article : Google Scholar : PubMed/NCBI
10	Bradley JR and Pober JS: Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene. 20:6482–6491. 2001. View Article : Google Scholar : PubMed/NCBI
11	Chung JY, Park YC, Ye H and Wu H: All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci. 115:679–688. 2002.PubMed/NCBI
12	Hayden MS and Ghosh S: Shared principles in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
13	Sun H, Li X, Fan L, Wu G, Li M and Fang J: TRAF6 is upregulated in colon cancer and promotes proliferation of colon cancer cells. Int J Biochem Cell Biol. 53:195–201. 2014. View Article : Google Scholar : PubMed/NCBI
14	Peng Z, Shuangzhu Y, Yongjie J, Xinjun Z and Ying L: TNF receptor-associated factor 6 regulates proliferation, apoptosis, and invasion of glioma cells. Mol Cell Biochem. 377:87–96. 2013. View Article : Google Scholar : PubMed/NCBI
15	Meng Q, Zheng M, Liu H, Song C, Zhang W, Yan J, Qin L and Liu X: TRAF6 regulates proliferation, apoptosis, and invasion of osteosarcoma cell. Mol Cell Biochem. 371:177–186. 2012. View Article : Google Scholar : PubMed/NCBI
16	Han Q, Yao F, Zhong C and Zhao H: TRAF6 promoted the metastasis of esophageal squamous cell carcinoma. Tumour Biol. 35:715–721. 2014. View Article : Google Scholar
17	Bilir C, Engin H, Can M, Likhan S, Demirtas D, Kuzu F and Bayraktaroglu T: Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer. Oncol Lett. 9:2819–2824. 2015.PubMed/NCBI
18	Zhang XL, Dang YW, Li P, Rong MH, Hou XX, Luo DZ and Chen G: Expression of tumor necrosis factor receptor-associated factor 6 in lung cancer tissues. Asian Pac J Cancer Prev. 15:10591–10596. 2014. View Article : Google Scholar
19	Lin G and Huang C, Su G, Hu H, Xu H and Huang C: Effect of TRAF6 downregulation on malignant biological behavior of lung cancer cell lines. Zhongguo Fei Ai Za Zhi. 18:661–667. 2015.In Chinese. PubMed/NCBI
20	Zhong L, Cao F and You Q: Effect of TRAF6 on the biological behavior of human lung adenocarcinoma cell. Tumour Biol. 34:231–239. 2013. View Article : Google Scholar
21	Starczynowski DT, Lockwood WW, Deléhouzée S, Chari R, Wegrzyn J, Fuller M, Tsao MS, Lam S, Gazdar AF, Lam WL, et al: TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer. J Clin Invest. 121:4095–4105. 2011. View Article : Google Scholar : PubMed/NCBI
22	Liu H, Zhang T, Ye J, Li H, Huang J, Li X, Wu B, Huang X and Hou J: TNF receptor-associated factor 6 in advanced non-small cell lung cancer: Clinical and prognostic implications. J Cancer Res Clin Oncol. 138:1853–1863. 2012. View Article : Google Scholar : PubMed/NCBI
23	Chen ZJ: Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol. 7:758–765. 2005. View Article : Google Scholar : PubMed/NCBI
24	Hoesel B and Schmid JA: The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013. View Article : Google Scholar
25	DiDonato JA, Mercurio F and Karin M: NF-κB and the link between inflammation and cancer. Immunol Rev. 246:379–400. 2012. View Article : Google Scholar : PubMed/NCBI
26	Karin M: Nuclear factor-kappaB in cancer development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
27	Karin M: NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol. 1:a0001412009. View Article : Google Scholar
28	Esencay M, Newcomb EW and Zagzag D: HGF upregulates CXCR4 expression in gliomas via NF-kappaB: Implications for glioma cell migration. J Neurooncol. 99:33–40. 2010. View Article : Google Scholar : PubMed/NCBI
29	Ju JH, Jang K, Lee KM, Kim M, Kim J, Yi JY, Noh DY and Shin I: CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells. Carcinogenesis. 32:1474–1483. 2011. View Article : Google Scholar : PubMed/NCBI
30	LaRocca TJ, Fabris F, Chen J, Benhayon D, Zhang S, McCollum L, Schecter AD, Cheung JY, Sobie EA, Hajjar RJ, et al: Na⁺/Ca²⁺ exchanger-1 protects against systolic failure in the Akita^ins2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway. Am J Physiol Heart Circ Physiol. 303:H353–H367. 2012. View Article : Google Scholar : PubMed/NCBI